Gardner, Ginger

Publications

Sort by

Co-Author Network

selected publications

Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 5
A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 13
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 16
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020 Academic Article GET IT
Times cited: 17
Evolution and outcomes of sentinel lymph node mapping in vulvar cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
Times cited: 18
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of gynecologic oncology. 2020 Academic Article GET IT
Times cited: 17
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecologic oncology. 2019 Academic Article GET IT
Times cited: 44
Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old. Annals of surgical oncology. 2018 Academic Article GET IT
Times cited: 12
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer. Gynecologic oncology. 2018 Academic Article GET IT
Times cited: 13
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?. Gynecologic oncology. 2018 Academic Article GET IT
Times cited: 50
Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 3
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 32
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 26
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2017 Academic Article GET IT
Times cited: 37
Abdominal wall endometriosis: differentiation from other masses using CT features. Abdominal radiology (New York). 2017 Academic Article GET IT
Times cited: 15
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 35
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 54
Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis. 2017 GET IT
Times cited: 23
Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 9
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 11
Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. Gynecologic oncology. 2016 Academic Article GET IT
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 35
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 3
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 47
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 66
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 95
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 8
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 28
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Academic Article GET IT
Times cited: 12
Is It Time to Centralize Ovarian Cancer Care in the United States?. Annals of surgical oncology. 2015 Review GET IT
Times cited: 43
Development of a risk stratification system to guide treatment for female germ cell tumors. Gynecologic oncology. 2015 Academic Article GET IT
Times cited: 28
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. Gynecologic oncology. 2015 Academic Article GET IT
Times cited: 65
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 162
Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstetrics and gynecology. 2014 Academic Article GET IT
Times cited: 54
The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 71
Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 216
Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 32
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2013 Academic Article GET IT
Times cited: 85
Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 45
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 28
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 19
Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 29
Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2013 Academic Article GET IT
Times cited: 21
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 56
Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 63
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 34
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstetrics and gynecology. 2012 Academic Article GET IT
Times cited: 39
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 14
Covered esophageal self-expandable metal stents in the nonoperative management of postoperative colorectal anastomotic leaks. Gastrointestinal endoscopy. 2012 Academic Article GET IT
Times cited: 23
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 55
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 17
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 85
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 25
Proceedings from the 9th International Conference on Ovarian Cancer. Gynecologic oncology. 2011 Conference Paper GET IT
Times cited: 1
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 15
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 65
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecologic oncology. 2011 Editorial Article GET IT
Times cited: 85
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group study. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 6
Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 62
Treatment of locally recurrent mucosal melanoma with topical imiquimod. 2011 GET IT
Times cited: 30
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 56
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT). Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 222
Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecologic oncology. 2011 Review GET IT
Times cited: 211
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 51
Current and future directions of clinical trials for ovarian cancer. Cancer control : journal of the Moffitt Cancer Center. 2011 Review GET IT
Times cited: 18
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 13
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 8
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2010 Academic Article GET IT
Times cited: 41
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 153
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk. American journal of obstetrics and gynecology. 2010 Academic Article GET IT
Times cited: 49
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 21
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. The oncologist. 2009 Academic Article GET IT
Times cited: 53
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 155
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 22
Ovarian cancer cytoreductive surgery in the elderly. Current treatment options in oncology. 2009 Review GET IT
Times cited: 7
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 96
Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Cancer. 2007 Academic Article GET IT
Times cited: 66
The role of cytoreductive surgery for colon cancer metastatic to the ovary. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 37
Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer. 2007 Academic Article GET IT
Times cited: 138
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 58
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 56
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 31
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene. 2006 Academic Article GET IT
Times cited: 96
Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 42
Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 33
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 58
Salvage cytoreductive surgery for recurrent endometrial cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 54
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 127
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer research. 2005 Academic Article GET IT
Times cited: 269
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 324
Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecologic oncology. 2005 Academic Article GET IT
Times cited: 53
Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases. Gynecologic oncology. 2005 Academic Article GET IT
Times cited: 36
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines. Cell death and differentiation. 2004 Academic Article GET IT
Times cited: 37
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 37
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells. Journal of medicinal chemistry. 2004 Academic Article GET IT
Times cited: 63
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 88
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential. Oncogene. 2002 Academic Article GET IT
Times cited: 53
Ovarian tumors of low malignant potential: Can molecular biology solve this enigma?. Journal of the National Cancer Institute. 2001 Editorial Article GET IT
Times cited: 5
Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2000 Academic Article GET IT
Times cited: 49
The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience. 1994 Academic Article GET IT
Times cited: 65

more ...

less ...

Background

education and training

B.A., M.D., Boston University School of Medicine 1996

Contact

full name

Ginger Gardner

VIVO Weill Cornell Medical College

Ginger Gardner Associate Professor of Obstetrics and Gynecology

Publications

selected publications

Background

education and training

Contact

full name